Abstract:Background Prediction of drug-disease interactions is promising for either drug repositioning or disease treatment fields. The discovery of novel drug-disease interactions, on one hand can help to find novel indictions for the approved drugs; on the other hand can provide new therapeutic approaches for the diseases. Recently, computational methods for finding drug-disease interactions have attracted lots of attention because of their far more higher efficiency and lower cost than the traditional wet experiment methods. However, they still face several challenges, such as the organization of the heterogeneous data, the performance of the model, and so on. Methods In this work, we present to hierarchically integrate the heterogeneous data into three layers. The drug-drug and disease-disease similarities are first calculated separately in each layer, and then the similarities from three layers are linearly fused into comprehensive drug similarities and disease similarities, which can then be used to measure the similarities between two drug-disease pairs. We construct a novel weighted drug-disease pair network, where a node is a drug-disease pair with known or unknown treatment relation, an edge represents the node-node relation which is weighted with the similarity score between two pairs. Now that similar drug-disease pairs are supposed to show similar treatment patterns, we can find the optimal graph cut of the network. The drug-disease pair with unknown relation can then be considered to have similar treatment relation with that within the same cut. Therefore, we develop a semi-supervised graph cut algorithm, SSGC, to find the optimal graph cut, based on which we can identify the potential drug-disease treatment interactions. Results By comparing with three representative network-based methods, SSGC achieves the highest performances, in terms of both AUC score and the identification rates of true drug-disease pairs. The experiments with different integration strategies also demonstrate that considering several sources of data can improve the performances of the predictors. Further case studies on four diseases, the top-ranked drug-disease associations have been confirmed by KEGG, CTD database and the literature, illustrating the usefulness of SSGC. Conclusions The proposed comprehensive similarity scores from multi-views and multiple layers and the graph-cut based algorithm can greatly improve the prediction performances of drug-disease associations.

SiSGC: A Drug Repositioning Prediction Model Based on Heterogeneous Simplifying Graph Convolution.

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Semi-supervised Graph Cut Algorithm for Drug Repositioning by Integrating Drug, Disease and Genomic Associations.

A computational drug repositioning model based on hybrid similarity side information powered graph neural network

GCNGAT: Drug–disease association prediction based on graph convolution neural network and graph attention network

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

Heterogeneous graph inference with matrix completion for computational drug repositioning

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks

SGCLDGA: Unveiling Drug-Gene Associations Through Simple Graph Contrastive Learning

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

A Novel Graph Representation Learning Model for Drug Repositioning Using Graph Transition Probability Matrix over Heterogenous Information Networks.

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

SLGCN: Structure-enhanced Line Graph Convolutional Network for Predicting Drug–disease Associations

Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration

Drug Repositioning Via Multi-view Representation Learning with Heterogeneous Graph Neural Network

DRGCL: Drug Repositioning Via Semantic-enriched Graph Contrastive Learning.

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network